Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF

NCT02808585 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: PB1046 Injection
DRUG: Placebo Injection

Sponsor

PhaseBio Pharmaceuticals Inc.